Guy Rochman, MD
Plastic and Reconstructive Surgery · Milton, MANPI 1669453361
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $114,000 of the $124,651 with a category attached, or 91.5%. Spectra Medical Devices, Inc. accounts for 77.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $48,271 and has fallen 100.0% since, to $15 in 2024. Among plastic and reconstructive surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $6232.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spectra Medical Devices, Inc.$96K
- Spectra Medical Devices, LLC$28K
- Smith+Nephew$175
- AbbVie$27
- Sientra, Inc.$17
What the payments were for
- Consulting fees$114,00091%
- Travel & lodging$10,4328%
- Food & beverage$2190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spectra Medical Devices, Inc. | 5 | $96,432 |
| Spectra Medical Devices, LLC | 2 | $28,000 |
| Smith+Nephew | 11 | $175 |
| AbbVie | 1 | $27 |
| Sientra, Inc. | 1 | $17 |
How this compares
$124,651 in reported general payments places this provider in the 95th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.
See all plastic and reconstructive surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 56 | $428 |
| Mupirocin | 11 | $71 |
| Doxycycline Hyclate | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Milton
- Kyle EberlinBoston$445K
- Dennis OrgillBoston$87K
- Glen BrooksLongmeadow$78K
- Jonathan FriedstatBoston$59K
- Ashley BoustanyBoston$46K
- Devin O'Brien-CoonBoston$34K
- Raymond DunnWorcester$31K
- Jonathan BekiszBoston$23K
- Krystle TuanoBoston$20K
- Christopher HomsyBoston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.